Home Careers Contact

Price: 3.85

Change: 0.00

Day High: 3.85
Day Low: 3.75
Volume: 923,861

4:00 PM ET | May 26, 2017
Delayed 20 min., by eSignal.



Shareholder Tools

Press Releases

Company News
View Summary Cempra Completes NDA Submissions for Solithromycin in the Treatment of Community-Acquired Bacterial Pneumonia
May 1, 2016
PDF 14.7 KB Add to Briefcase
View Summary Cempra to Report First Quarter 2016 Financial Results
Apr 25, 2016
PDF 11.5 KB Add to Briefcase
View Summary Cempra to Present at the Needham and Company 15th Annual Healthcare Conference
Apr 6, 2016
PDF 11.7 KB Add to Briefcase
View Summary Cempra to Present Data on Solithromycin at ECCMID
Apr 4, 2016
PDF 15.7 KB Add to Briefcase
View Summary Cempra to Participate in Nature's Webcast on Combating Antibiotic Resistance on March 9
Mar 8, 2016
PDF 14.0 KB Add to Briefcase
View Summary Cempra Authorized to Receive Funds From BARDA for a Phase 2/3 Clinical Trial of Solithromycin in Pediatric Patients
Mar 7, 2016
PDF 17.0 KB Add to Briefcase
View Summary Cempra to Present at the Cowen and Company 36th Annual Healthcare Conference
Feb 29, 2016
PDF 11.6 KB Add to Briefcase
View Summary Cempra Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
Feb 24, 2016
PDF 29.2 KB Add to Briefcase
View Summary Cempra to Report Fourth Quarter and Full Year 2015 Financial Results
Feb 17, 2016
PDF 11.4 KB Add to Briefcase
View Summary The Lancet Infectious Diseases Publishes Positive Phase 3 Study Results for Cempra's Oral Solithromycin in Community-Acquired Bacterial Pneumonia
Feb 5, 2016
PDF 17.9 KB Add to Briefcase
Showing 41-50 of 232 Page: 1 2 3 4 5 6 7 8 9 ... 24  Previous 10 | Next 10
Add to Briefcase = add release to Briefcase